Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
Guardado en:
Autores principales: | Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleó, Jurgen A. H. R. Claassen, Marcel M. Verbeek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8bd655e7a32b48debbc472ad6cbb7185 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Tainá M. Marques, et al.
Publicado: (2021) -
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
por: Zhen-Yi Andy Ou, et al.
Publicado: (2021) -
COVID‐19‐associated thrombotic angiopathy improved after plasma exchange
por: Natalie Elkayam, et al.
Publicado: (2021) -
Palinopsia as an initial symptom of cerebral amyloid angiopathy-related inflammation
por: Hitomi Onomura, et al.
Publicado: (2021) -
Early MRI imaging and follow-up study in cerebral amyloid angiopathy
por: Zhang Shan-chun, et al.
Publicado: (2021)